ANDREA KNOX: Open Payments
NPI 1154728467 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,744 in 114 payments from 42 companies in 2025. Trend: 2023 $1,276 · 2024 $1,531 · 2025 $2,744
Food & beverage: $2,744
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $278 |
| Merck Sharp & Dohme LLC | 9 | $218 |
| AstraZeneca Pharmaceuticals LP | 9 | $216 |
| Regeneron Healthcare Solutions, Inc. | 8 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $134 |
| Janssen Biotech, Inc. | 5 | $116 |
| Daiichi Sankyo Inc. | 4 | $110 |
| SOBI, INC | 5 | $98 |
| GENZYME CORPORATION | 3 | $97 |
| Incyte Corporation | 4 | $97 |
Products named: KEYTRUDA, LIBTAYO, KISQALI, Enhertu, Lenvima, Vonjo, SARCLISA, NERLYNX.
Industry payments across TN — which companies pay providers there.
